:max_bytes(133120)/d2j5s05om7evfr.cloudfront.net/pubmed-llm-images/41593539/e27eb85d485ee31dd72e5c738eeed3fc_wm.png)
Impact of glucocorticoid therapy on short- and long-term mortality in immunocompromised patients with community-acquired pneumonia in the ICU: a retrospective cohort study.
Summary: When people with weak immune systems get a severe lung infection called pneumonia, they often need to stay in the intensive care unit (ICU). Doctors sometimes treat them with steroids (glucocorticoids) to help calm down the swelling in their lungs. But does this actually help these specific patients?
Researchers looked at the medical records of 1,770 patients to find out. They discovered that patients who were given steroids actually had a higher chance of dying within 28 days compared to those who did not get the medicine. The risk of dying stayed higher even six months and a year later. The researchers noticed that the risk was worst when the steroids were started too late (after 48 hours), given for too long (more than 7 days), or given in very low doses. Because of this, doctors need to be very careful and do more research before using steroids for these patients.